14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ATOS stock ended at $1.70. This is 1.16% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 6.59% from a day low at $1.67 to a day high of $1.78.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Nov 22, 2016 $22.32 $24.96 $22.08 $22.08 8 327
Nov 21, 2016 $21.24 $22.68 $20.52 $22.32 18 803
Nov 18, 2016 $21.00 $21.72 $20.28 $21.36 10 956
Nov 17, 2016 $21.48 $23.04 $19.80 $21.00 6 185
Nov 16, 2016 $21.00 $22.08 $20.76 $21.24 4 747
Nov 15, 2016 $19.80 $21.12 $19.44 $20.64 5 119
Nov 14, 2016 $21.36 $24.00 $19.80 $20.28 15 943
Nov 11, 2016 $21.96 $23.28 $19.80 $21.12 9 313
Nov 10, 2016 $19.44 $21.36 $19.44 $21.24 5 596
Nov 09, 2016 $18.60 $20.40 $18.36 $19.56 7 524
Nov 08, 2016 $19.08 $19.80 $18.72 $18.96 6 359
Nov 07, 2016 $19.80 $19.80 $19.20 $19.32 4 292
Nov 04, 2016 $21.60 $21.60 $19.32 $19.56 2 692
Nov 03, 2016 $22.20 $22.44 $21.00 $21.36 2 642
Nov 02, 2016 $22.68 $25.08 $20.64 $21.96 12 908
Nov 01, 2016 $22.80 $28.56 $22.56 $23.04 111 625
Oct 31, 2016 $18.60 $28.20 $18.36 $22.08 44 008
Oct 28, 2016 $18.60 $19.56 $18.00 $18.24 1 167
Oct 27, 2016 $18.48 $19.32 $18.48 $18.84 1 833
Oct 26, 2016 $20.16 $22.20 $18.96 $19.68 5 600
Oct 25, 2016 $20.28 $20.40 $18.60 $19.80 6 275
Oct 24, 2016 $20.40 $20.76 $19.08 $20.04 583
Oct 21, 2016 $20.64 $21.60 $18.84 $21.60 2 217
Oct 20, 2016 $21.36 $21.60 $20.64 $20.64 375
Oct 19, 2016 $21.60 $22.08 $21.00 $21.60 1 158
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT